BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹43 Cr | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | 12.71 | |
| Mar2025 | ₹38 Cr | -14.36 | |
| Mar2024 | ₹45 Cr | 18.02 | |
| Mar2023 | ₹38 Cr | 4.32 | |
| Mar2022 | ₹36 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹145.5 Cr | -7.6% | -10.3% | 16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -7.6% |
-10.3% |
16.1% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses